| Z |
| Z Nafissi |
- |
National Program for Prevention of Hemophilia in Iran |
| Za T |
- |
Risk of Recurrent Venous Thromboembolism Associated with Inherited Deficiency of Natural Anticoagulants |
| Zabe-KühnM |
- |
In Silico Design and in Vitro Validation of a Mimotope for Blocking a FVIII-inhibitor Antibody ESH8 |
| Zaccanelli M |
- |
The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma |
| Zacharias C |
- |
Use of Helixate®NexGen in the Treatment of Patients with Haemophilia A: A Long-Term Pharmacovigilance Surveillance |
| Zachary IC |
- |
Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly |
| Zachoval R |
- |
Antiviral Treatment of HCV Infected Young Haemophiliacs An Update of 12 Years Experience |
| Zadjali S |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| |
- |
Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman |
| Zadro R |
- |
Is it Possible to Predict the Degree of FVIII Deficiency from aPTT Waveform Analysis on Behring Coagulation Timer (BCT) |
| |
- |
Factor XIII Val34Leu Polymorphism in Croatian Population |
| Zadro R |
- |
Improvement of STA: STACLOT APC-R Test for the Detection of Factor V Leiden by Using APCR Ratio |
| Zahedi PR |
- |
An Approach to Elucidate the Platelet Membrane Proteome |
| Zakarija A |
- |
Fondaparinux Use in Heparin-Induced Thrombocytopenia |
| Zakarija A |
- |
Catastrophic Antiphospholipid Antibody Syndrome: Successful Treatment with Immunosuppresive Therapy and Plasmapheresis |
| |
- |
Tissue Factor: Lack of the Cytoplasmic Tail Results in Generation of Functional Microparticle-Associated Tissue Factor |
| Zala N |
- |
Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported |
| Zalavras C |
- |
Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis |
| Zalloua P |
- |
Prenatal Diagnosis in a Lebanese Family with Severe Factor VII Deficiency |
| Zaman K |
- |
High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study |
| |
- |
Thromboelastography Is a Useful Predictor of Stent Thrombosis |
| Zambon A |
- |
A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL |
| Zamboni P |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Zampieri P |
- |
Cerebral Venous Thrombosis: The Padua Experience |
| Zamurovic D |
- |
Pediatric Thrombosis |
| Zanardelli S |
- |
ADAMTS13 Substrate Recognition of the Von Willebrand Factor A2 Domain |
| Zanazzi M |
- |
High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism |
| Zandstra DF |
- |
The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria |
| Zangari M |
- |
High Incidence and Transitory Nature of Acquired Resistance to Activated Protein C (aAPCR) in Patients with Multiple Myeloma |
| Zanon E |
- |
Acute Myocardial Infarction in Haemophillia A or B Patients: A Cardiological Evaluation of 44 Reported Cases |
| |
- |
Non-Catheter Induced Venous Thrombosis in Haemophellia A E B Patients |
| |
- |
Oral Contraceptives in the Management of Rare Coagulation Bleeding Disorders |
| |
- |
Gene Mutation and ITT Response in the Italian Cohort of Patients with Haemophilia A |
| |
- |
High Prevalence of Cardiac Abnormalities in Patients with Congenital FV Deficiency |
| Zarkova A |
- |
Treatment of Congenital Coagulation Disorders in Countries with Limited Financial Resources Bulgarian Experience |
| |
- |
Clinical Efficacy and Safety of Wilate, a Novel, High-purity VWF/FVIII-Concentrate with Optimized Pharmacokinetic Properties in the Treatment of von Willebrand Disease |
| Zarr C |
- |
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin |
| Zaspel A |
- |
Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis |
| Zaujec J |
- |
Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development |
| Zavalova L |
- |
Microvessel Hemostasis Is Inhibited by Medicinal Leech Salivary Gland Secretion |
| Zawadzki C |
- |
Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization |
| Zayed Saleh H |
- |
Platelet Functions and Markers of Platelet Activation in Coronary Artery Bypass Grafting (CABG) with or without Cardiopulmonary Bypass (CPB) |
| Zdravkovic S |
- |
Pediatric Thrombosis |
| Zega A |
- |
New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold Antithrombotic Effect in Two Rat Venous Thrombosis Models |
| Zehender M |
- |
Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation |
| Zehnder JL |
- |
Identification and Molecular Characterization of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding |
| Zehnder JL |
- |
Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia? |
| Zeinali S |
- |
Carrier Detection and Prenatal Diagnosis of Two Short Tandem Repeats within Factor VIII Gene in Iranian Population |
| |
- |
Carrier Testing of Hemophilia B by SSCP and Sequencing in One Iranian Family |
| Zekanowska E |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| Zelinskas C |
- |
Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties |
| Zellner M |
- |
Protein Profiling of Human Blood Platelets from Young and Aged Individuals |
| Zemani F |
- |
Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells |
| Zemlyanskaya O |
- |
Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions |
| Zeng SY |
- |
Changes of Factor VII Coagulant Activity in Oral Warfarin Patients |
| Zerbinati P |
- |
Clinical and Molecular Characterization of Three Italian Patients with Severe Factor V Deficiency and Bleeding Disorder (Parahaemophilia): Report of a Novel Homozygous Mutation (FV: Asp524His) |
| |
- |
The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study |
| |
- |
Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study) |
| Zetser A |
- |
Effect of Heparanase on TF Expression and TFPI Release |
| Zhai Z |
- |
Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients |
| Zhang L |
- |
Sporadic Occurrence of Warfarin Resistance Secondary to a Val29Leu Mutation In The VKORC1 Protein |
| Zhang G |
- |
Blockade of Microvascular Endothelial Cell Replication, Migration, Tubule Formation, Matrix Angiogenesis and Retinal Neovascularization by siRNA Targeting the Basic Region-Leucine Zipper Transcription Factor cJun |
| Zhang Y |
- |
The Generation of Thrombin by High Dose Recombinant Factor VIIa Can Be Mimicked by Lower Factor VIIa Concentrations Combined with Tissue Factor |
| Zhang W |
- |
Inactivation of the Human Platelet cGMP-Induced cAMP Phosphodiesterase (PDE3A) by Affinity Labeling of an Octapeptide in the Unique 44 Amino Acid Flexible Loop |
| Zhang X |
- |
Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties |
| Zhang DW |
- |
Changes of Factor VII Coagulant Activity in Oral Warfarin Patients |
| Zhang L |
- |
Isolated Alpha-2 Antiplasmin Deficiency Presenting in a 63 year Old Man |
| Zhang Z |
- |
Hereditary Plasminogen Activator Inhibitor-1 Deficiency Related to Ala15Thr Mutation in Its Signal Peptide |
| Zhang W |
- |
Hereditary Plasminogen Activator Inhibitor-1 Deficiency Related to Ala15Thr Mutation in Its Signal Peptide |
| Zhang R-L |
- |
Alteration of Protein Z in Malignant Tumors and Its Significance |
| Zhang W |
- |
Thrombin Regulates cAMP Level in Human Platelets through Phosphorylation/Activation of Akt |
| Zhang H |
- |
Effects of Angiotensin-(17) on the Expression of Tissue Factor Induced by Angiotensin II and its Mechanisms in Vascular Endothelial Cells |
| Zhang J |
- |
Prourokinase Activation Is the Speed-limited Step of Its Catalyzed Plasminogen Activation |
| Zhang J |
- |
Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China |
| Zhang JW |
- |
Anti-b2 Glycoprotein I (b2GPI) and Anti-Annexin A2 Antibodies Stimulate the Release of Microparticles from Endothelial Cells |
| Zhang C |
- |
Hydrogen Peroxide Activation of Platelet-Derived Growth Factor D-chain Transcription Is Mediated by the Winged Helix-Turn-Helix Protein Ets-1 and its Interplay with Sp1 |
| Zhang L |
- |
Production of a Recombinant Peptide Substrate for the Fluorescence Based Assay of ADAMTS13 |
| Zhao Y |
- |
Tetramethylpyrazine Inhibits Apoptotic Cell Death of Cultured Endothelial Cells Induced by Tumor Necrosis Factor-alpha |
| Zhao X |
- |
A Novel Deletion Mutation of Von Willebrand Factor Associated with Type 3 Von Willebrand Disease |
| Zhao L |
- |
Effects of Granulocyte-Colony Stimulating Factor on Platelet and Leukocyte Function in Whole Blood in vitro |
| Zhao L |
- |
Dietary Flavanols Effects on Platelets and Leukocytes |
| Zhegu Z |
- |
TECHNOZYM® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13 |
| Zheng X |
- |
Apical Sorting of ADAMTS13 in Madin-Darby Canine Kidney (MDCK) Cells Depends on an Association with Detergent-Insoluble Sphingolipid and Cholesterol-Enriched Rafts |
| Zheng Y |
- |
Gene Targeting or Pharmacological Inhibition of Rac GTPases Prolongs the Bleeding Time and Reduces Platelet Adhesion, Secretion and Aggregation: Evidence for the Rac-Mediated Activation of MAP Kinases during Platelet Activation |
| Zheng H |
- |
Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency |
| Zheng S-X |
- |
NF-kB Activation Mediates Deep Vein Thrombosis: Inhibition by the NF-kB Inhibitor Andrographolide and Its Derivatives |
| Zheng X |
- |
The Proximal C-terminal Domains of ADAMTS13 Determine the Recognition and Cleavage of Peptidyl Substrate VWF73 and Macromolecular Substrate von Willebrand Factor |
| Zhenyi W |
- |
Novel Aberrant Splicings Caused by a Splice Site Mutation IVS1a+5g > a in F7 Gene |
| Zhou X |
- |
Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population |
| Zhou W |
- |
Recombinant ADAMTS13 Refractory to Suppression by TTP Inhibitors |
| Zhou SY |
- |
The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia |
| Zhou J |
- |
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis |
| Zhou H |
- |
Venous Thromboembolism in 68 142 Patients with Colorectal Cancer |
| Zhou W-X |
- |
Alteration of Protein Z in Cardio-Cerebra Thrombotic Diseases and Its Significance |
| Zhou H |
- |
Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM) |
| |
- |
Rates of Venous Thromboembolism (VTE) in Californians with Cancer |
| Zhu Y |
- |
Treatment with Gelatin Absorbed Clodronate in the Management of Immune Thrombocytopenic Purpura in a Rat Model |
| Zhu H |
- |
Removal of Hirudin-Like Sequences within the Factor Va Heavy Chain Does Not Impair Prothrombinase Function |
| Zhu G |
- |
Additional Environmental and Genetic Factors Are Required to Trigger TTP in ADAMTS13-Deficient Mice |
| Zhu J |
- |
Platelet Antibody Analysis in Patients with Platelet Transfusion Refractoriness |
| Zhu H |
- |
Characterization of B-Domain Sequences on Factor V Which Influence the Procofactor to Cofactor Transition |
| Zhuang YP |
- |
Haemostatic Characters during Liver Transplantation with Preoperative DIC |
| Zhukov O |
- |
ELISA for Detecting Immune Responses to Factor VIII |
| Zhukova A |
- |
PAR3 Expression and Functions Studied with Blocking, Cleavage Site-Specific Antibodies |
| Zibara K |
- |
An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions |
| Zibis A |
- |
Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis |
| Zieger BDu¨ringC |
- |
Risk of Recurrent Venous Thromboembolism in Children with Cerebral Venous Thrombosis A Prospective Follow-Up Cohort Study |
| Zieger B |
- |
Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors |
| Ziegler H |
- |
Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions |
| Zielinski C |
- |
High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma |
| Ziemer S |
- |
Drugs with Anti-Prion Activity in Cell Culture Have Variable Effects on the Stimulation of Plasmin Generation by the Prion Protein NH2-terminal Fragment PrP23-110 |
| |
- |
A Concept for Preoperative Identification of Patients with Impaired Primary Hemostasis |
| |
- |
A Concept for Preoperative Management of Patients with Impaired Primary Hemostasis |
| Zighetti ML |
- |
Platelet Aggregation Studies: Autologous Platelet-Poor Plasma Inhibits Platelet Aggregation When Added to Platelet-Rich Plasma to Normalize Platelet Count |
| Zignego AL |
- |
More Carotid Atherosclerosis in HCV Positive Italian Patients? |
| Zimanova J |
- |
Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer |
| Zimmermann R |
- |
Self-assessment of Bleeding in Young Women Results from a Multicenter Questionnaire |
| |
- |
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses |
| |
- |
Comparative Study of Fibrinolysis Test Systems with A Special Focus on Variable Sample Handling (Different Transport Modalities/Arterial and Venous Catheterization) |
| |
- |
Successful Inhibitor-Elimination with Rituximab in Acquired Hemophilia A and a Patient with a Carrier Status for Hemophilia A Two Case Reports |
| |
- |
Home Treatment of Bleeding Episodes in Haemophiliacs With Inhibitors: Cost-Effectiveness of Three on-Demand Strategies in Germany |
| Zimnoch L |
- |
Heterogeneous Expression of Components of Protein C (PC) System in Human Colon Cancer Tissue |
| |
- |
Immunohistochemical Localization of Protein Z (ZP) and Protein Z-Dependent Protease Inhibitor (ZPI) in Situ in Human Malignant Tumors |
| Zingali RB |
- |
Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor |
| Zito F |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| Zitouni M |
- |
Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study |
| Zitzmann N |
- |
Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets |
| Zivelin A |
- |
Concomitant Infusion of Low Doses of rFVIIa and FEIBA in Severe Hemophilia A Patients with an Inhibitor to Factor VIII Who Are Refractory to rFVIIa or FEIBA Has an Excellent Hemostatic Effect and Synergistically Enhances Thrombin Generation |
| |
- |
Mechanisms of Thrombin Generation Induced by High Concentrations of Recombinant Factor VIIa |
| |
- |
Absence of Exon V Deleted Factor XI mRNA in Homozygous Factor XI Deficiency |
| Zivelin A |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| Zlokovic BV |
- |
Activated Protein C |
| Zlotzover M |
- |
ProC Global Assay in the Evaluation of Women at Risk for VTE While Using Hormonal Therapy |
| Zogg M |
- |
Thrombophilia-Associated Fetal Loss: Epistasis of Fetal and Maternal Factors |
| Zoghlami C |
- |
High Levels of Anti-protein Z Immunoglobulin G and M Antibodies, Persistent Lupus Anticoagulant and Thrombosis |
| Zografidis A |
- |
Population Pharmacokinetics of the ReFacto® Factor VIII for Prophylactic Treatment of HIV- and HIV+ Individuals with Haemophilia A |
| Zoheir Mostafa N |
- |
Platelet Functions and Markers of Platelet Activation in Coronary Artery Bypass Grafting (CABG) with or without Cardiopulmonary Bypass (CPB) |
| Zohra A |
- |
Drug-induced Thrombocytopenia: Mapping of the binding Site of the Rifampicin-dependent Antibody on GPIX |
| Zondag M |
- |
Predictors of Mid-interval Low Molecular Weight Heparin Anti-Xa Levels |
| |
- |
Residual Anticoagulant Activity Following Bridging Low Molecular Weight Heparin: Prevalence and Risk Factors |
| Zorio E |
- |
Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease |
| Zotz RB |
- |
Reeavaluation of 75 Patients with Previous Diagnosis of von Willebrand Disease |
| Zotz RB |
- |
New Approach for Evaluation of Quantitative Risk Factors of Venous Thromboembolism Using Individualized Reference Values |
| Zotz RB |
- |
Premature Onset of Fetal Loss Is Associated with the Polymorphism of Platelet Membrane Integrin a2b1 (a2807TT) |
| Zotz R |
- |
Treatment of Glanzmann's Thrombasthenia (GT): A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII (rFVIIa) and Other Hemostatic Agents |
| Zotz RB |
- |
The IVS1-401 T-Allele of the Estrogen Receptor (ER)-a is an Independent Predictor of Late Fetal Loss |
| Zotz RB |
- |
Closure Times Determined with a Platelet Function Analyzer are Closely Correlated to the Mean Transvalvular Gradient in Patients with Aortic-Valve Stenosis |
| Zotz RB |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| Zotz RB |
- |
The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia |
| |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| |
- |
Influence of Gender, Age, and Oral Contraception on Hemostatic Parameters Determined by Rotation Thrombelastography |
| |
- |
Modulation of Platelet Adhesion by Antithrombin |
| |
- |
The 807C/T Polymorphism in the a-Subunit of Integrin a2b1 Modulates Platelet Adhesion onto Immobilized Collagen Under Arterial Flow Conditions |
| |
- |
Anticoagulation with Danaparoid in Two Pregnant Women with Valve Prosthesis and Heparin-Induced Thrombocytopenia Type II (HIT Typ II) |
| |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units |
| Zotz RB |
- |
Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism |
| Zou Y |
- |
Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China |
| Zouain D |
- |
Analysis of Factor VIII Gene Intron 1 Inversion in Brazilian Patients with Severe Haemophilia A |
| Zouaoui Boudjeltia K |
- |
Circulating Platelet-Monocyte Complexes Are Inversely Correlated with Serum Apo-A Levels |
| Zozulya NI |
- |
Results of Home Treatment for Patients with Using Factor VIII Concentrate Hemoctin STD |
| |
- |
The National Register of Patients with Inherited Coagulopathies in Russia |
| Zuazu-Jausoro I |
- |
Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder |
| Zubiaga M |
- |
The Crystal Structure of Unliganded Thrombin Identifies Regions Involved in Allosteric Regulation by Thrombomodulin |
| Zubilewicz T |
- |
Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD |
| ZubilewiczH[lstrok]awacz-Paszczyk TB |
- |
The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction |
| Zucker ML |
- |
A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System |
| Zucker M |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| Zucker ML |
- |
Effective Anticoagulation Self-Management in a Diverse Population of Oral Anticoagulation Patients Using the Protime System |
| Zucker M |
- |
Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests |
| |
- |
Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI) |
| Zuehlsdorf M |
- |
Effect of Enoxaparin on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 an Oral, Direct Factor Xa Inhibitor |
| |
- |
Aspirin Has No Effect on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 597939 An Oral, Direct Factor Xa Inhibitor |
| Zufferey P |
- |
Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials |
| Zulfikar B |
- |
rFVIIa (NovoSeven®) for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients with Inhibitors: A Double-Blind Study of a Single High Dose Versus Standard Multiple Doses of rFVIIa |
| |
- |
Retrospective Open Multicenter Study on the Efficacy and Safety of Activated Prothrombin Complex (Feiba®) in Haemorrhage and Surgical Interventions in Haemophilia Patients with Inhibitor and in Patients with Rare Bleeding Disorders in Turkey |
| Zulfikar H |
- |
Retrospective Open Multicenter Study on the Efficacy and Safety of Activated Prothrombin Complex (Feiba®) in Haemorrhage and Surgical Interventions in Haemophilia Patients with Inhibitor and in Patients with Rare Bleeding Disorders in Turkey |
| Zurbano MJ |
- |
DG-Chrom AT: A New Commercial Antithrombin (AT) Assay (Anti-FXa) |
| Zverkova A |
- |
Haemostasis Is Regulated through Nicotinic Acetylcholine Receptors |
| Zwaal R |
- |
Phosphatidylserine Exposure During Platelet Stimulation Is Caused by Activation of Scramblase and Inactivation of Aminophospholipid Translocase in a Distinct Platelet Fraction |
| Zwang E |
- |
A New Approach for Pre Analytical Screening of Hospitalized Patients Receiving Anticoagulant Therapy |
| Zwinderman AH |
- |
Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study |